Roundup Non-Hodgkins Lymphoma Lawsuit
Partnering with doctors to offer powerful patient resources
MedLogic works with physicians and their patients who may have suffered as a result of defective products, including drugs and devices. We identify the resources patients need to determine if they are eligible for recoveries.
Roundup® Non-Hodgkin's Lymphoma
Non-Hodgkin’s lymphoma refers to a group of blood cancers that develop from white blood cells. Studies have shown an increased risk of developing non-Hodgkin’s lymphoma after exposure to the glyphosate weed killer sold under the brand name Roundup®1. Roundup was manufactured and sold by Monsanto until 2018, when the brand name and the product line were acquired by Bayer.
Federal court juries determined that Monsanto was aware of the risks associated with exposure to Roundup and failed to notify the public. These juries have awarded billions to those who developed non-Hodgkin’s after exposure to Roundup2. If your patients have been diagnosed with non-Hodgkin’s lymphoma or Chronic Lymphocytic Leukemia and have been exposed to Roundup, they may be eligible to file a claim.
1LuPong, Zhang; Rana, Iemaan; Schaeffer, Rachel M., Taioli; Emanuela & Sheppard, Lianee. Exposure to glyphosate-based herbicide and risk for non-Hodgkin’s lymphoma: A meta-analysis and supporting data. Elsevier Science Direct. Volume 781, July-September, 2019. pp. 186-206.
2Cohen, Patricia. $2 Billion Dollar Verdict Against Monsanto Is Third to Find Roundup Caused Cancer. The New York Times. May 13, 2019
Resources for Non-Hodgkin’s Lymphoma
Lymphoma Foundation of America